BiotechTube
BRIDGenomics

BRIDGenomics

San Diego, United States· Est.
bridgenomics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Founded in 2015 and based in San Diego, BRIDGenomics operates as a niche consulting firm within the genetics, genomics, and diagnostics sector. The company provides expert guidance on technical assay development, scalable commercialization strategies, and regulatory processes for molecular diagnostics, with a strong emphasis on Next-Generation Sequencing. It serves as an intermediary, connecting clients with the right technology partners, manufacturers, and laboratories to optimize their market approach. BRIDGenomics' business model is purely service-based, generating revenue through its consulting expertise rather than developing its own diagnostic products.

Genetics & GenomicsDiagnostics

Technology Platform

Consulting expertise and network focused on technical assay development, regulatory strategy, and commercialization for molecular diagnostics, with deep specialization in Next-Generation Sequencing.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The rapid growth and technical complexity of the NGS and molecular diagnostics market create strong demand for specialized consulting services.
The trend towards companion diagnostics and personalized medicine requires strategic integration of drug and diagnostic development, a key area of BRIDGenomics' expertise.
Evolving global regulatory landscapes for IVDs and LDTs present ongoing challenges that clients need help navigating.

Risk Factors

Revenue is dependent on a project-based consulting model, making it variable and sensitive to client R&D budget cycles.
The business is highly reliant on the reputation and retention of a small core team of experts.
Competition from other consultancies and internal client teams requires constant demonstration of differentiated value.

Competitive Landscape

BRIDGenomics competes with a range of players including large life science consulting firms (e.g., Clarivate, IQVIA), boutique specialist consultancies, independent solo consultants, and the internal development teams of potential clients. Its differentiation lies in its specific, deep focus on NGS-based assay development and commercialization, combined with its stated mission to actively bridge industry segments through partnership facilitation.

More companies in Diagnostics & Precision Medicine →More companies in United States →